SUN PHARMACEUTICAL INDUSTRIES
|
|
| BOM : 524715     NSE : SUNPHARMA     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Average |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Dec 19,2025 |
|
Price(EOD): ₹ 1,745.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 418,701.84 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -1.8% | -2.5% |
| DIVIS LABORATORIES | 2.1% | 0.2% | 9.1% |
| CIPLA | 0.7% | -0.8% | 3.4% |
| TORRENT PHARMACEUTICALS | 0.5% | 2.2% | 11.2% |
| DR REDDYS LABORATORIES | -0.1% | 2.5% | 2.5% |
| MANKIND PHARMA | 1.5% | -2.8% | -19.5% |
| ZYDUS LIFESCIENCES | -0.2% | -0.8% | -5.7% |
| LUPIN | 1.7% | 4.7% | 3.5% |
| AUROBINDO PHARMA | 3.3% | 1.4% | -0.3% |
FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SUN PHARMACEUTICAL INDUSTRIES
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
39.81
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 10,517.90 Cr
[Latest Qtr - Sep2025 - Consolidated Results ] 5.8
P/B Calculated based on Book Value of Rs 72,218.00 Cr
[Latest Year - Mar2025 - Consolidated Results ] 7.62
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 54,964.00 Cr
[Latest Qtr - Sep2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
51% 7% 6% |
SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES
SUN PHARMACEUTICAL INDUSTRIES vs SENSEX
DEBT OF SUN PHARMACEUTICAL INDUSTRIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.45 0.47 0.32 0.41 |
0.03 0.04 0.11 0.06 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF SUN PHARMACEUTICAL INDUSTRIES
| Pledged Promoter Shares |
0.97 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF SUN PHARMACEUTICAL INDUSTRIES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.53% 0.59% 31.36% 36.24% |
8.93% 7.5% 15.84% 3.51% |
| QtrlyTrend |
8 | |
| Latest Qtr: Sep2025 | ||
| Quarterly Result Analysis → | ||
SUN PHARMACEUTICAL INDUSTRIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
| BSE DIVIDEND STABILITY INDEX | 0.3% | -0.1% | 0.1% |
| BSE SENSEX SIXTY 65:35 | -0.1% | -0.3% | 3.9% |
| BSE LOW VOLATILITY INDEX | -0.1% | -0.7% | 3.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY GROWTH SECTORS 15 | 0.3% | 1.1% | 2.5% |
| NIFTY100 LOW VOLATILITY 30 | -0.1% | -0% | 6.7% |
| NIFTY 500 EQUAL WEIGHT | -0.1% | -2.6% | -4.7% |
| NIFTY ALPHA QUALITY VALUE LOW-VOLATILITY 30 | -0.1% | 0.2% | 0.4% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -0.1% | -1.6% | -2% |
You may also like the below Video Courses
FAQ about SUN PHARMACEUTICAL INDUSTRIES
Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?
As on Dec 19,2025, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?
As on Dec 19,2025, SUN PHARMACEUTICAL INDUSTRIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?
As on Dec 19,2025, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,635.16 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,151.99
Fair Value [Median EV / Sales Model] : Rs. 1,635.16
Fair Value [Median Price / Sales Model] : Rs. 1,644.86
Estimated Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,635.16
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.